rs201152809

Variant summary

Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBS1_SupportingBS2

The NM_002025.4(AFF2):​c.561C>A​(p.Asp187Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000421 in 1,210,003 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 17 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.000054 ( 0 hom., 2 hem., cov: 23)
Exomes 𝑓: 0.000041 ( 0 hom. 15 hem. )

Consequence

AFF2
NM_002025.4 missense

Scores

2
15

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 0.121

Publications

2 publications found
Variant links:
Genes affected
AFF2 (HGNC:3776): (ALF transcription elongation factor 2) This gene encodes a putative transcriptional activator that is a member of the AF4\FMR2 gene family. This gene is associated with the folate-sensitive fragile X E locus on chromosome X. A repeat polymorphism in the fragile X E locus results in silencing of this gene causing Fragile X E syndrome. Fragile X E syndrome is a form of nonsyndromic X-linked cognitive disability. In addition, this gene contains 6-25 GCC repeats that are expanded to >200 repeats in the disease state. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Jul 2016]
AFF2 Gene-Disease associations (from GenCC):
  • FRAXE intellectual disability
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -7 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.09731996).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0000537 (6/111770) while in subpopulation NFE AF = 0.000113 (6/53184). AF 95% confidence interval is 0.0000484. There are 0 homozygotes in GnomAd4. There are 2 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Hemizygotes in GnomAd4 at 2 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AFF2NM_002025.4 linkc.561C>A p.Asp187Glu missense_variant Exon 3 of 21 ENST00000370460.7 NP_002016.2 P51816-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AFF2ENST00000370460.7 linkc.561C>A p.Asp187Glu missense_variant Exon 3 of 21 5 NM_002025.4 ENSP00000359489.2 P51816-1
AFF2ENST00000342251.7 linkc.549C>A p.Asp183Glu missense_variant Exon 3 of 20 1 ENSP00000345459.4 P51816-3
AFF2ENST00000370457.9 linkc.561C>A p.Asp187Glu missense_variant Exon 3 of 20 1 ENSP00000359486.6 P51816-6
AFF2ENST00000370458.5 linkc.549C>A p.Asp183Glu missense_variant Exon 3 of 8 1 ENSP00000359487.1 P51816-4

Frequencies

GnomAD3 genomes
AF:
0.0000537
AC:
6
AN:
111770
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000113
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000273
AC:
5
AN:
183428
AF XY:
0.0000295
show subpopulations
Gnomad AFR exome
AF:
0.0000760
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000488
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000410
AC:
45
AN:
1098233
Hom.:
0
Cov.:
32
AF XY:
0.0000413
AC XY:
15
AN XY:
363587
show subpopulations
African (AFR)
AF:
0.0000379
AC:
1
AN:
26403
American (AMR)
AF:
0.00
AC:
0
AN:
35207
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19384
East Asian (EAS)
AF:
0.0000331
AC:
1
AN:
30206
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54145
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40533
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4137
European-Non Finnish (NFE)
AF:
0.0000499
AC:
42
AN:
842122
Other (OTH)
AF:
0.0000217
AC:
1
AN:
46096
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000537
AC:
6
AN:
111770
Hom.:
0
Cov.:
23
AF XY:
0.0000589
AC XY:
2
AN XY:
33950
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30703
American (AMR)
AF:
0.00
AC:
0
AN:
10525
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2640
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3565
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2657
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6073
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
239
European-Non Finnish (NFE)
AF:
0.000113
AC:
6
AN:
53184
Other (OTH)
AF:
0.00
AC:
0
AN:
1499
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000170
Hom.:
1
Bravo
AF:
0.0000151
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000297
AC:
2
ExAC
AF:
0.0000330
AC:
4

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Uncertain:1
Oct 10, 2016
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Uncertain:1
Sep 26, 2022
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.561C>A (p.D187E) alteration is located in exon 3 (coding exon 3) of the AFF2 gene. This alteration results from a C to A substitution at nucleotide position 561, causing the aspartic acid (D) at amino acid position 187 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.083
BayesDel_addAF
Benign
-0.38
T
BayesDel_noAF
Benign
-0.60
CADD
Benign
13
DANN
Uncertain
0.99
DEOGEN2
Benign
0.20
T;.;.;.
FATHMM_MKL
Uncertain
0.77
D
LIST_S2
Benign
0.71
T;T;T;T
M_CAP
Benign
0.031
D
MetaRNN
Benign
0.097
T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.9
L;.;.;L
PhyloP100
0.12
PrimateAI
Benign
0.42
T
PROVEAN
Benign
-1.1
N;N;N;.
REVEL
Benign
0.054
Sift
Benign
0.058
T;T;T;.
Sift4G
Benign
0.31
T;T;T;T
Polyphen
0.77
P;P;P;P
Vest4
0.12
MutPred
0.32
Gain of methylation at K192 (P = 0.1338);.;.;Gain of methylation at K192 (P = 0.1338);
MVP
0.58
MPC
0.13
ClinPred
0.083
T
GERP RS
1.6
Varity_R
0.14
gMVP
0.14
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201152809; hg19: chrX-147743809; API